[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606419":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":17,"locations":27,"responsibleParty":43,"collaborators":7,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":7,"eligibilityCriteria":50,"healthyVolunteers":51,"sex":52,"minAge":53,"maxAge":7,"enrollmentInfo":54,"targetDuration":57,"studyType":58,"phases":7,"briefSummary":59,"conditions":60,"keywords":62,"overallStatus":30,"whyStopped":7,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Asociación para Evitar la Ceguera en México","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","Multimodal imaging findings","Fundus photography, Optical Coherence Tomography, and Fluorescein Angiography will be performed 7 days after meeting the criteria for inactivation of endophthalmitis, as outlined in the MEX-ESG guidelines. These imaging tests will be repeated one month after meeting the inactivation criteria.",[14],{"name":15,"affiliation":5,"role":16},"Raul Velez Montoya, MD","PRINCIPAL_INVESTIGATOR",[18,23],{"name":19,"role":20,"phone":21,"phoneExt":7,"email":22},"Raúl Velez Montoya, MD","CONTACT","(52) 55 5436 7335","rvelezmx@yahoo.com",{"name":24,"role":20,"phone":25,"phoneExt":7,"email":26},"Benjamín Aboytes Ríos, MD","4772329592","benaborivers@gmail.com",[28],{"facility":29,"status":30,"city":31,"state":7,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Hospital Asociación Para Evitar la Ceguera en México I.A.P.","RECRUITING","Mexico City","04030","Mexico","MX",{"type":36,"coordinates":37},"Point",[38,39],-99.12766,19.42847,{"lat":39,"lon":38},[42],{"name":24,"role":20,"phone":25,"phoneExt":7,"email":26},{"type":44,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100606419","vascular-changes-associated-with-endophthalmitis-100606419",false,"NCT07175311","Vascular Changes Associated With Endophthalmitis.","Inclusion Criteria:\n\n* Patients with a history of endophthalmitis Diagnosis of Endophthalmitis\n* Clinical symptoms: Pain, decrease in visual acuity, anterior chamber cells and\u002For vitreous turbidity, corneal edema, conjunctival hyperemia\n* Laboratory studies: B-mode USG and or positive culture\n* Patients who meet the endophthalmitis resolution criteria of the Mexican Endophthalmitis Study Group\n* Patients with previously signed informed consent\n\nExclusion Criteria:\n\n* Patients who have not signed the informed consent\n* Patients under 18 years.\n* Patients with endophthalmitis who do not meet the resolution criteria of the Mexican Endophthalmitis Study Group",true,"ALL","18 Years",{"count":55,"type":56},71,"ESTIMATED","6 Weeks","OBSERVATIONAL","This study aims to describe and investigate vascular changes associated with exogenous endophthalmitis, as well as to create a photo library where they are evidenced",[61],"Endophthalmitis",[63,64],"Postoperative endophthalmitis","Multimodal imaging","2025-09-09",{"date":67,"type":68},"2025-09-16","ACTUAL",{"date":70,"type":68},"2024-11-01",{"date":72,"type":56},"2026-03-01",{"name":5,"class":6},1]